Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA010926 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA010926, RRID:AB_1078449
- Product name
- Anti-ALCAM
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human ALCAM, Gene description: activated leukocyte cell adhesion molecule, Alternative Gene Names: CD166, MEMD, Validated applications: IHC, Uniprot ID: Q13740, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.05 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer
Elevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome
Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non–small-cell lung cancer
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
Nicolau-Neto P, de Souza-Santos P, Severo Ramundo M, Valverde P, Martins I, Costa Santos I, Dias F, de Almeida Simão T, Ribeiro Pinto L
Cancers 2020;12(2):470
Cancers 2020;12(2):470
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer
Tyekucheva S, Bowden M, Bango C, Giunchi F, Huang Y, Zhou C, Bondi A, Lis R, Van Hemelrijck M, Andrén O, Andersson S, Watson R, Pennington S, Finn S, Martin N, Stampfer M, Parmigiani G, Penney K, Fiorentino M, Mucci L, Loda M
Nature Communications 2017;8(1)
Nature Communications 2017;8(1)
Elevated ALCAM Shedding in Colorectal Cancer Correlates with Poor Patient Outcome
Hansen A, Freeman T, Arnold S, Starchenko A, Jones-Paris C, Gilger M, Washington M, Fan K, Shyr Y, Beauchamp R, Zijlstra A
Cancer Research 2013;73(10):2955-2964
Cancer Research 2013;73(10):2955-2964
Membranous expression of activated leukocyte cell adhesion molecule contributes to poor prognosis and malignant phenotypes of non–small-cell lung cancer
Ishiguro F, Murakami H, Mizuno T, Fujii M, Kondo Y, Usami N, Taniguchi T, Yokoi K, Osada H, Sekido Y
Journal of Surgical Research 2013;179(1):24-32
Journal of Surgical Research 2013;179(1):24-32
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
Kahlert C, Weber H, Mogler C, Bergmann F, Schirmacher P, Kenngott H, Matterne U, Mollberg N, Rahbari N, Hinz U, Koch M, Aigner M, Weitz J
British Journal of Cancer 2009;101(3):457-464
British Journal of Cancer 2009;101(3):457-464
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human parathyroid gland and skeletal muscle tissues using HPA010926 antibody. Corresponding ALCAM RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
